285 related articles for article (PubMed ID: 10340913)
1. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
Scheffler MR; Colburn W; Kook KA; Thomas SD
Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
[TBL] [Abstract][Full Text] [Related]
3. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
4. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
5. The interaction between St John's wort and an oral contraceptive.
Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
Kearney BP; Mathias A
Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
[TBL] [Abstract][Full Text] [Related]
8. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
9. Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers.
Teo SK; Colburn WA; Thomas SD
J Clin Pharmacol; 1999 Nov; 39(11):1162-8. PubMed ID: 10579147
[TBL] [Abstract][Full Text] [Related]
10. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
Yu Z; Yu D; Walker PS; Tang-Liu DD
Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
[TBL] [Abstract][Full Text] [Related]
12. Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers.
Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Hoetelmans RM
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):118-28. PubMed ID: 24161160
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol.
van Giersbergen PL; Halabi A; Dingemanse J
Int J Clin Pharmacol Ther; 2006 Mar; 44(3):113-8. PubMed ID: 16550733
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate.
Terlinden R; Uragg H; Göhler K; Kneip C
Contraception; 2006 Sep; 74(3):239-44. PubMed ID: 16904418
[TBL] [Abstract][Full Text] [Related]
15. Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone.
LeBel M; Masson E; Guilbert E; Colborn D; Paquet F; Allard S; Vallée F; Narang PK
J Clin Pharmacol; 1998 Nov; 38(11):1042-50. PubMed ID: 9824786
[TBL] [Abstract][Full Text] [Related]
16. Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers.
Butler K; Teng R
Curr Med Res Opin; 2011 Aug; 27(8):1585-93. PubMed ID: 21692601
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
[TBL] [Abstract][Full Text] [Related]
18. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
19. Dirithromycin increases ethinyl estradiol clearance without allowing ovulation.
Wermeling DP; Chandler MH; Sides GD; Collins D; Muse KN
Obstet Gynecol; 1995 Jul; 86(1):78-84. PubMed ID: 7784027
[TBL] [Abstract][Full Text] [Related]
20. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.
Murphy PA; Kern SE; Stanczyk FZ; Westhoff CL
Contraception; 2005 Jun; 71(6):402-8. PubMed ID: 15914127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
